Skip to the answer

Methylprednisolone Uses, Dosage, Side Effects and Interactions

Brand names
Medrol

Medrol was the first methylprednisolone product the FDA approved, in 1957. An FDA-approved generic with the same active ingredient is listed.

HybriSil

HybriSil is a brand name for methylprednisolone. It is not in the FDA’s directory today; generic methylprednisolone is.

Solu-medrol

Solu-medrol is a methylprednisolone brand from before 1982 that comes as an injection. An FDA-approved generic with the same active ingredient is listed.

Depo-Medrol

Depo-Medrol is a methylprednisolone brand from before 1982 that comes as an injection. An FDA-approved generic with the same active ingredient is listed.

Methylprednisolone is a corticosteroid (steroid anti-inflammatory medicine) given as tablets or injections to treat allergic conditions, skin diseases, hormone (adrenal) disorders, and rheumatic (joint and muscle) conditions.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About MethylprednisoloneType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Methylprednisolone in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Methylprednisolone is a strong corticosteroid (steroid anti-inflammatory) that quiets inflammation and the immune system in severe allergies, skin diseases, rheumatic conditions such as rheumatoid arthritis and some adrenal (hormone) disorders, a familiar standby on the U.S. market since about 1957 with FDA-approved generics listed. Short courses are usually well tolerated, though many people notice a bigger appetite, poor sleep or mood swings; longer use can bring weight gain, a rounded face and higher blood sugar. It lowers resistance to infection and can hide the signs, so get checked for fever or chills and call promptly after any chicken pox or measles exposure.

Key Takeaways From the HelloPharmacist Team

  • Follow the tablet step-down schedule exactly, since doses are lowered gradually to the lowest amount that works; injections are always given by a professional.
  • Never stop long-term treatment suddenly; your body’s own steroid production can stay low for months, so mention it before surgery or illness.
  • Avoid adding ibuprofen, naproxen or aspirin on your own, since combined with a steroid they raise the risk of stomach and gut problems.
  • If you have diabetes, check your blood sugar more often, since steroids push it up and diabetes medicine doses may need adjusting.

How we write and review this content: our editorial policy

Methylprednisolone by the Numbers

Strengths
21
across 2 forms
Makers and packagers
41
Earliest FDA record
1957
Rank by Medicaid prescriptions
#89 of 1,682 drugs
More prescriptions than 94% of the 1,682 drugs we measure
2.62 million prescriptions, Q1–Q4 2025
Other forms and routes

Patient Information Guide for Methylprednisolone

What It’s Used For

Methylprednisolone is used for many inflammatory, allergic and hormone-related conditions. Uses differ by product.

  • Injections (Depo-Medrol and methylprednisolone acetate, by muscle): severe allergic conditions such as asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness and transfusion reactions.
  • Injections: skin diseases such as pemphigus, dermatitis herpetiformis, mycosis fungoides and severe erythema multiforme (Stevens-Johnson syndrome).
  • Injections: adrenal insufficiency (adrenal glands not making enough hormone).
  • Methylprednisolone sodium succinate (by vein or muscle): allergic states, skin diseases and endocrine disorders when oral therapy is not feasible.
  • Medrol and methylprednisolone tablets (by mouth): adrenal insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis (thyroid inflammation) and high calcium linked to cancer.
  • Medrol and methylprednisolone tablets: short-term add-on treatment for rheumatic conditions such as rheumatoid arthritis, ankylosing spondylitis, bursitis, gouty arthritis and psoriatic arthritis.
  • Medrol and methylprednisolone tablets: collagen diseases such as systemic lupus erythematosus and dermatomyositis.

Drug Class

Drug Class

  • Corticosteroid
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Corticosteroid

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Corticosteroid Hormone Receptor Agonists

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Methylprednisolone in the FDA’s index.

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Methylprednisolone in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Corticosteroids, potent (group III)
  • Corticosteroids, weak (group I)
  • Glucocorticoids

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Tablets are taken by mouth. Injections are given by a healthcare professional into a muscle, joint, skin lesion or vein, depending on the product.

  • The starting amount depends on the condition. It is adjusted to your response.
  • After improvement, the amount is lowered gradually to the lowest that works.
  • Injectable products should not be diluted or mixed with other solutions.

Follow your prescriber's instructions and the product label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Methylprednisolone Injection

Conditions needing high dose steroid treatment
For adults and children
Usual dose 30 mg/kg
  • 30 mg/kg administered intravenously over at least 30 minutes
  • May be repeated every 4 to 6 hours for 48 hours

Good to know

High dose therapy usually not continued beyond 48 to 72 hours

These are the doses for children. For adults, see “Conditions needing high dose steroid treatment.”

Asthma
For children
Usual dose 1 to 2 mg/kg a day
  • 1 to 2 mg/kg/day in single or divided doses
  • Short course 'burst' continued until peak expiratory flow rate of 80% of personal best or symptoms resolve, usually 3 to 10 days
Multiple sclerosis flare-ups
For adults
Starting dose 160 mg of methylprednisolone a day for a week Usual dose 64 mg every other day for 1 month
  • 160 mg of methylprednisolone daily for a week followed by 64 mg every other day for 1 month
Other Doses
Adults · Starting dose Starting dose 10 to 40 mg of methylprednisolone
  • 10 to 40 mg of methylprednisolone depending on the specific disease entity being treated
Children · Starting dose Starting dose 0.11 to 1.6 mg/kg a day in three or four divided doses
  • 0.11 to 1.6 mg/kg/day in three or four divided doses (3.2 to 48 mg/m2 bsa/day)

Good to know

Should not be less than 0.5 mg per kg every 24 hours

BSA means body surface area, worked out from height and weight.

See the Full Dosing Instructions on DailyMed →

Depo-Medrol and Medroloan SUIK

Rheumatoid arthritis and osteoarthritis
Adults with large joints (knees, ankles, shoulders) Usual dose 20 to 80 mg
  • 20 to 80 mg intra-articular
  • May be repeated at intervals of one to five or more weeks
Adults with medium joints (elbows, wrists) Usual dose 10 to 40 mg
  • 10 to 40 mg intra-articular
  • May be repeated at intervals of one to five or more weeks
Adults with small joints Usual dose 4 to 10 mg
  • 4 to 10 mg intra-articular
  • May be repeated at intervals of one to five or more weeks
Initial parenteral dosage, methylprednisolone acetate injectable suspension Starting dose 4 to 120 mg
  • 4 to 120 mg depending on the specific disease entity being treated

See the Full Dosing Instructions on DailyMed →

Methylprednisolone Taken by Mouth

Multiple sclerosis flare-ups
Adults Starting dose 200 mg of prednisolone a day for a week Usual dose 80 mg of prednisolone every other day for 1 month
  • 200 mg of prednisolone daily for a week followed by 80 mg of prednisolone every other day for 1 month (4 mg of methylprednisolone is equivalent to 5 mg of prednisolone)
Adults · Starting dose Starting dose 4 mg to 48 mg of methylprednisolone a day
  • 4 mg to 48 mg of methylprednisolone per day depending on the specific disease entity being treated

Good to know

Lower doses generally suffice in less severe situations

See the Full Dosing Instructions on DailyMed →

Side Effects

Common effects of corticosteroids include:

Common side effects

  • Increased appetite and weight gain
  • Nausea
  • Trouble sleeping, mood swings or depression
  • Headache or dizziness
  • Acne, thin or fragile skin, easy bruising
  • Fluid retention and higher blood pressure
  • Higher blood sugar
  • Moon face (rounded face) or muscle weakness

When to get medical help

  • Signs of infection such as fever or chills. Steroids can hide or worsen infections.
  • Chicken pox or measles exposure. These can be more serious while on corticosteroids.
  • Allergic reaction signs such as swelling of the face or throat, hives or trouble breathing.
  • Black or bloody stools, or severe stomach pain, which may signal ulcer or bowel problems.
  • Vision changes, eye pain or glaucoma symptoms.
  • Bone, hip or shoulder pain, or a sudden tendon problem.
  • Severe mood or personality changes, or seizures.
  • Chest pain, swelling or sudden shortness of breath.

Warnings and Precautions

  • Infections: steroids lower your defenses, can hide infection signs, and can worsen tuberculosis, fungal and other infections.
  • Adrenal suppression: long-term use can suppress your natural steroid hormones. Lower the dose gradually rather than stopping suddenly.
  • Heart, blood pressure and fluids: steroids can raise blood pressure and cause salt and water retention and potassium loss. Use with great caution after a recent heart attack.
  • Eyes: cataracts, glaucoma and eye infections are possible.
  • Vaccines: live or weakened vaccines should not be given at immune-suppressing doses.
  • Chicken pox and measles: exposure can be more serious.
  • Injections: skin dents can form at the injection site, and injection into the deltoid muscle should be avoided.
  • Head injury: high doses should not be used for traumatic brain injury.

Interactions

Several medicines can change how methylprednisolone works or raise side-effect risks.

  • Warfarin: its effect may be reduced, so clotting is monitored.
  • Aspirin and NSAIDs: more stomach and gut side effects.
  • Diabetes medicines: steroids raise blood sugar.
  • Diuretics and amphotericin B: low potassium risk.
  • Digoxin: low potassium can raise the risk of rhythm problems.
  • Ketoconazole and erythromycin-type antibiotics: can raise steroid levels.
  • Phenytoin, carbamazepine, barbiturates and rifampin: can lower steroid levels.
  • Cyclosporine: effects of both increase, and seizures have been reported.
  • Estrogens, including birth control pills: can increase steroid effect.
  • Cholestyramine: can speed steroid clearance.
  • Isoniazid: levels may be lower.
  • Anticholinesterase drugs: may cause severe weakness in myasthenia gravis.
  • Vaccines and skin tests: responses may be reduced.

Interactions Listed in the FDA-Approved Label

From the Methylprednisolone prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Aminoglutethimide
    What happensMay lead to a loss of corticosteroid-induced adrenal suppression.
  • Amphotericin B and potassium-depleting agents For example: diuretics
    What happensTogether with corticosteroids may cause hypokalemia; amphotericin B with hydrocortisone was followed by cardiac enlargement and congestive heart failure.
    What to doObserve patients closely for hypokalemia.
  • Macrolide antibiotics
    What happensReported to cause significant decrease in corticosteroid clearance.
  • Anticholinesterases
    What happensMay produce severe weakness in patients with myasthenia gravis.
    What to doIf possible, withdraw anticholinesterase agents at least 24 hours before starting corticosteroid therapy.
  • Oral anticoagulants (warfarin)
    What happensUsually results in inhibition of response to warfarin, although reports conflict.
    What to doMonitor coagulation indices frequently.
  • Antidiabetics
    What happensCorticosteroids may increase blood glucose concentrations.
    What to doDosage adjustments of antidiabetic agents may be required.
  • Antitubercular drugs (isoniazid)
    What happensSerum concentrations of isoniazid may be decreased.
  • Cholestyramine
    What happensMay increase the clearance of oral corticosteroids.
  • What happensIncreased activity of both cyclosporine and corticosteroids may occur; convulsions have been reported.
  • Digitalis glycosides
    What happensIncreased risk of arrhythmias due to hypokalemia.
Read the label’s full interactions text

Clinically Significant Drug Interactions: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. In situations when concurrent therapy is necessary, careful patient monitoring is essential. Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents. Phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine.

DRUG INTERACTIONS Aminoglutethimide Aminoglutethimide may lead to a loss of corticosteroid-induced adrenal suppression. Amphotericin B injection and potassium- depleting agents When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. There have been cases reported in which concomitant use of amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure. Antibiotics Macrolide antibiotics have been reported to cause significant decrease in corticosteroid clearance (see DRUG INTERACTIONS, Hepatic Enzyme Inhibitors ) Anticholinesterases Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy. Anticoagulants, oral Coadministration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports. Therefore, coagulation indices should be monitored frequently to maintain the desired anticoagulant effect.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use if allergic to methylprednisolone or its ingredients.
  • Methylprednisolone acetate injectable suspension should not be given into the spinal canal.
  • Methylprednisolone acetate injectable suspension should not be used in premature infants, because it contains benzyl alcohol.
  • Intramuscular steroid injections should not be used with idiopathic thrombocytopenic purpura.
  • Methylprednisolone acetate injectable suspension should not be used in systemic fungal infections, except for joint injection for a localized joint condition.
  • Tell your prescriber about tuberculosis, other infections, diabetes, heart disease or high blood pressure.
  • Tell your prescriber about ulcers or bowel disease, eye problems such as glaucoma or ocular herpes, and myasthenia gravis.
  • Tell your prescriber about recent travel to the tropics or unexplained diarrhea.
  • Avoid exposure to chicken pox and measles if you have not had them.

Overdose

Acute overdose is treated with supportive and symptomatic care. For long-term overdose in someone who needs ongoing steroid therapy, the dose may be reduced temporarily, or alternate-day treatment may be used.

Storage

Protect from light. Store unreconstituted product at controlled room temperature 20° to 25°C (68° to 77°F) . Store reconstituted solution (not further diluted) at controlled room temperature 20° to 25°C (68° to 77°F) , and use it within 48 hours.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Methylprednisolone

From the licensed clinical database we use, rolled up per supplement, most serious first.

211 supplements and herbal products have documented interactions with Methylprednisolone in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 4Major
  • 169Moderate
  • 38Minor

See the other 203

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Nutrients Methylprednisolone May Deplete

Nutrients Methylprednisolone has been linked with lower levels of, from the licensed clinical database we use.

Methylprednisolone has been associated with lower levels of 9 nutrients in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

Evidence and significance: 5 moderate, 1 lower / possible, 3 unrated

See the other 1

Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.

Methylprednisolone: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Methylprednisolone — the kind of thing our pharmacy team would talk through with you at the counter.

What is methylprednisolone used for?

It is a steroid that treats many inflammatory and allergic conditions. These include severe allergies, skin diseases, adrenal gland problems and rheumatic conditions such as rheumatoid arthritis. The exact use depends on whether you have tablets or an injection.

Can I stop methylprednisolone suddenly?

Don't stop on your own, especially after long use. Steroids can suppress your body's natural hormone production. Lowering the dose gradually helps your body recover, so talk to your prescriber first.

What side effects should I expect?

Increased appetite, weight gain, trouble sleeping, mood changes, acne, fluid retention and higher blood sugar are common. Call your doctor for signs of infection, black stools, vision changes, severe mood changes or an allergic reaction.

Does methylprednisolone interact with other medicines?

Yes. Tell me about warfarin, aspirin or NSAIDs, diabetes medicines, water pills, digoxin, antibiotics such as erythromycin, ketoconazole, seizure medicines and cyclosporine. Some raise side-effect risks and others change steroid levels.

Can I get vaccines while taking it?

Live or weakened vaccines should not be given if you're on immune-suppressing doses. Inactivated vaccines can be given, but your response may be weaker. Check with your prescriber before any vaccine.

Should I worry about chicken pox or measles?

Yes. These infections can be more serious while you're on steroids. If you haven't had them, avoid exposure and tell your doctor right away if you are exposed.

Is methylprednisolone available over the counter?

No. Methylprednisolone is a prescription medicine: every methylprednisolone product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was methylprednisolone first available?

The earliest FDA record we hold for methylprednisolone is from 1957: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when methylprednisolone was first used.

Who makes methylprednisolone?

41 companies currently list methylprednisolone products in the FDA's NDC Directory, including Pharmacia & Upjohn Company LLC, A-S Medication Solutions, Amneal Pharmaceuticals LLC. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of methylprednisolone?

Methylprednisolone is the generic name. Its brand names are Medrol, HybriSil, Solu-medrol and Depo-Medrol. Generic versions are listed under the name methylprednisolone.

What is the generic name of Medrol?

The generic name of Medrol is methylprednisolone. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is methylprednisolone?

Methylprednisolone belongs to the drug class Corticosteroid, its established pharmacologic class on the FDA label.

Is there a generic version of methylprednisolone?

Yes. FDA-approved generic versions of methylprednisolone are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does methylprednisolone come in?

Methylprednisolone is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (into a joint, into a lesion, into a muscle, into a vein, into soft tissue): 40 mg, 125 mg, 125 mg/2 mL, 500 mg, 500 mg/4 mL, 500 mg/8 mL, 1 g, 1 g/8 mL, 1 g/16 mL, 2 g and 1 more. Injection (into a joint, into a lesion, into a muscle, into a vein, into soft tissue), amount in each mL: 20 mg/mL, 40 mg/mL, 80 mg/mL, 500 mg/mL and 1 g/mL. Tablet (by mouth): 2 mg, 4 mg, 8 mg, 16 mg and 32 mg. A listing does not mean every pharmacy stocks every strength.

How much does methylprednisolone cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $5.57 to $11.92 per mL of the generic injection across 2 strengths, $3.27 each for the generic injection across 2 strengths, $6.69 to $11.93 per mL of the injection of brand-name Depo-Medrol across 2 strengths and $6.28 to $10.04 each for the injection of brand-name Solu-medrol across 2 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a methylprednisolone shortage?

Yes. Methylprednisolone is on the FDA's drug shortage list as of Nov 22, 2026. A shortage means some products are hard to get, not that every pharmacy is out. The shortage page lists the affected products and what each company has told the FDA. Read the methylprednisolone shortage page

Where can I read the methylprednisolone prescribing information (package insert)?

The full FDA-approved prescribing information for methylprednisolone, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Pharmacia & Upjohn Company LLC's, revised Jun 25, 2026, and links to it on DailyMed.

Is methylprednisolone gluten free?

No methylprednisolone label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten. We read the FDA labels of 133 methylprednisolone products from 41 companies. Of those, 5 name a starch, dextrin or maltodextrin without saying where it comes from, so for those the answer is "source unclear", not "no". A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's methylprednisolone by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See methylprednisolone inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Methylprednisolone

Skip the scrolling. Ask in your own words and get an answer from Methylprednisolone’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Methylprednisolone’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Methylprednisolone on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Methylprednisolone Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Methylprednisolone Forms and Strengths (How It Comes)

Methylprednisolone comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Methylprednisolone inactive ingredients by manufacturer.

Injection

Into a blood vessel · Into a joint · Into a lesion · Into a muscle · Into a vein · Into soft tissue
Brands Solu-medrol (before 1982) Depo-Medrol (before 1982)
How this form is used
What it may be used for
  • Depo-Medrol and methylprednisolone acetate injectable suspension are used by muscle injection for allergic, skin and endocrine conditions when oral therapy is not feasible.
  • Methylprednisolone sodium succinate for injection is used by vein or muscle injection when oral therapy is not feasible.
Important instructions
  • Depo-Medrol and methylprednisolone acetate should not be diluted or mixed with other solutions.
  • Methylprednisolone sodium succinate is reconstituted before use with only Water for Injection or Bacteriostatic Water for Injection.
  • Some methylprednisolone acetate and Depo-Medrol injections contain benzyl alcohol.
Available strengths 16 strengths
Show 10 more strengths Show fewer strengths
81 FDA-listed product records ⓘ

Tablet

By mouth
Brands Medrol (the first brand, 1957)
How this form is used
What it may be used for
  • Medrol and methylprednisolone tablets are used for endocrine (hormone) disorders, rheumatic disorders and collagen diseases such as systemic lupus erythematosus.
Important instructions
  • Medrol tablets: the starting amount depends on the condition. It is adjusted to your response, then lowered gradually to the lowest effective amount.
  • Medrol is stopped and other therapy is considered if there is no satisfactory response.
Available strengths 5 strengths
53 FDA-listed product records ⓘ

Methylprednisolone on the U.S. Market: Products, Makers and Brands

How Methylprednisolone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

41 companies list 133 Methylprednisolone product records with the FDA, mostly as injection, tablet; the earliest marketing or approval year on record is 1957. Brand names in the directory today include Medrol, Solu-medrol and Depo-Medrol; the rest are generics.

2
Dose forms ⓘ
41
Labelers (makers, repackagers, distributors)
4
Brand names ⓘ
133
FDA-listed product records ⓘ
1957
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (36) · Crystal (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Pharmacia & Upjohn Company LLC12%
A-S Medication Solutions7%
Amneal Pharmaceuticals LLC5%
Eugia US LLC5%
Remedyrepack Inc.5%
Asclemed USA, Inc.4%
Other makers63%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Methylprednisolone Is Used (Medicaid Data)

How many Methylprednisolone prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

2,620,269
Medicaid prescriptions filled (Q1–Q4 2025)
$37M paid by Medicaid, before rebates

How commonly is Methylprednisolone prescribed? Of the 1,682 medications we measure, Methylprednisolone ranks #89 by Medicaid prescriptions — more than 95% of them.

Where Methylprednisolone ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Methylprednisolone product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 1 mL / 40 mg/mL injection is the most-dispensed Methylprednisolone product — about 7% of these Medicaid prescriptions.

1 ML methylprednisolone acetate 40 MG/ML Injection Most dispensed

170,388 Medicaid prescriptions (Q1–Q4 2025) 7% of Methylprednisolone prescriptions shown $3.1M paid by Medicaid, before rebates ≈ $18 per prescription, before rebates

8 of 24 listed NDCs had Medicaid claims. RxNorm 1743779

1 ML methylprednisolone acetate 80 MG/ML Injection

132,017 Medicaid prescriptions (Q1–Q4 2025) 5% of Methylprednisolone prescriptions shown $2.4M paid by Medicaid, before rebates ≈ $18 per prescription, before rebates

10 of 23 listed NDCs had Medicaid claims. RxNorm 1743855

methylprednisolone 125 MG Injection

127,763 Medicaid prescriptions (Q1–Q4 2025) 5% of Methylprednisolone prescriptions shown $6.1M paid by Medicaid, before rebates ≈ $47 per prescription, before rebates

6 of 36 listed NDCs had Medicaid claims. RxNorm 1743704

methylprednisolone acetate 40 MG/ML Injectable Suspension

127,640 Medicaid prescriptions (Q1–Q4 2025) 5% of Methylprednisolone prescriptions shown $2.8M paid by Medicaid, before rebates ≈ $22 per prescription, before rebates

12 of 27 listed NDCs had Medicaid claims. RxNorm 1358610

methylprednisolone 4 MG Oral Tablet

58,990 Medicaid prescriptions (Q1–Q4 2025) 2% of Methylprednisolone prescriptions shown $621,363 paid by Medicaid, before rebates ≈ $11 per prescription, before rebates

7 of 63 listed NDCs had Medicaid claims. RxNorm 259966

methylprednisolone acetate 80 MG/ML Injectable Suspension

50,796 Medicaid prescriptions (Q1–Q4 2025) 2% of Methylprednisolone prescriptions shown $1.3M paid by Medicaid, before rebates ≈ $25 per prescription, before rebates

9 of 12 listed NDCs had Medicaid claims. RxNorm 1358617

methylprednisolone 40 MG Injection

36,587 Medicaid prescriptions (Q1–Q4 2025) 1% of Methylprednisolone prescriptions shown $1.2M paid by Medicaid, before rebates ≈ $33 per prescription, before rebates

6 of 27 listed NDCs had Medicaid claims. RxNorm 311659

methylprednisolone acetate 20 MG/ML Injectable Suspension

19,944 Medicaid prescriptions (Q1–Q4 2025) <1% of Methylprednisolone prescriptions shown $320,507 paid by Medicaid, before rebates ≈ $16 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 1358510

methylprednisolone 62.5 MG/ML Injectable Solution

10,669 Medicaid prescriptions (Q1–Q4 2025) <1% of Methylprednisolone prescriptions shown $1.1M paid by Medicaid, before rebates ≈ $100 per prescription, before rebates

8 of 15 listed NDCs had Medicaid claims. RxNorm 314099

methylprednisolone 8 MG Oral Tablet

4,515 Medicaid prescriptions (Q1–Q4 2025) <1% of Methylprednisolone prescriptions shown $145,022 paid by Medicaid, before rebates ≈ $32 per prescription, before rebates

2 of 18 listed NDCs had Medicaid claims. RxNorm 197973

methylprednisolone 16 MG Oral Tablet

3,206 Medicaid prescriptions (Q1–Q4 2025) <1% of Methylprednisolone prescriptions shown $88,105 paid by Medicaid, before rebates ≈ $27 per prescription, before rebates

2 of 18 listed NDCs had Medicaid claims. RxNorm 328161

methylprednisolone 32 MG Oral Tablet

2,816 Medicaid prescriptions (Q1–Q4 2025) <1% of Methylprednisolone prescriptions shown $48,836 paid by Medicaid, before rebates ≈ $17 per prescription, before rebates

3 of 17 listed NDCs had Medicaid claims. RxNorm 197971

methylprednisolone 1000 MG Injection

1,289 Medicaid prescriptions (Q1–Q4 2025) <1% of Methylprednisolone prescriptions shown $160,278 paid by Medicaid, before rebates ≈ $124 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 1743726

methylprednisolone 500 MG Injection

1,099 Medicaid prescriptions (Q1–Q4 2025) <1% of Methylprednisolone prescriptions shown $52,463 paid by Medicaid, before rebates ≈ $48 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 1743720

methylprednisolone 2000 MG Injection

188 Medicaid prescriptions (Q1–Q4 2025) <1% of Methylprednisolone prescriptions shown $120,312 paid by Medicaid, before rebates ≈ $640 per prescription, before rebates

1 of 4 listed NDCs had Medicaid claims. RxNorm 1357886

Other Methylprednisolone products: packs and listings not matched to one strength and form

1,872,362 Medicaid prescriptions (Q1–Q4 2025) 71% of Methylprednisolone prescriptions shown $17.6M paid by Medicaid, before rebates ≈ $9.39 per prescription, before rebates

7 of 112 listed NDCs had Medicaid claims.

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 84 of the 399 listed Methylprednisolone NDCs had Medicaid claims.

Compare Methylprednisolone Products

A representative set of FDA-listed product records for Methylprednisolone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 133 of 133 products — FDA National Drug Code Directory. See every product, package size and price: browse all 133 Methylprednisolone NDCs →

Methylprednisolone Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Methylprednisolone — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Methylprednisolone are fatigue, pain, nausea; about 89% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

173,369
Reports mentioning it
89%
Reported as serious
12
Distinct effects shown
Most reported effects
Fatigue
10,616
Pain
10,098
Nausea
9,714
Headache
9,666
Pyrexia
9,283
Dyspnoea
8,944
Arthralgia
8,382
Pneumonia
8,369
Diarrhoea
8,225
Condition Aggravated
7,824
Age groups
Adult · 18,219Elderly · 7,517Child · 1,554Adolescent · 965Neonate · 576Infant · 464

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Methylprednisolone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Methylprednisolone FDA Approval History

How Methylprednisolone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Methylprednisolone was first approved by the FDA in 1957 (Brand: MEDROL · Pfizer); the first generic version was approved in 1964. It remains available in U.S. pharmacies today.

1957
Brand approved
Brand: MEDROL · Pfizer
1964
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Methylprednisolone Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list 4 Methylprednisolone recalls since July 2021, covering 5 product listings. Three of them are still ongoing or began in the last six months and are listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class II Jan 15, 2026 · Greenstone Llc
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
  • methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2 Lots: Lot # LG7675, Exp. Date Nov 2026 FDA record D-0299-2026 →
Ongoing Class II Apr 25, 2024 · Sagent Pharmaceuticals
Presence of Particulate Matter: Potential for black particulates in the drug product.
  • MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC:… Lots: Lots 5100186, 5100187, 5100188, 5100189, Exp 01/31/2025 FDA record D-0499-2024 →
Ongoing Class II Feb 20, 2024 · Eugia US LLC
Failed Dissolution Specifications
  • Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01 Lots: Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025 FDA record D-0366-2024 →
Class II Apr 13, 2022 · Terminated · Mckesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
  • Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 80mg/mL, packaged in a) 1 mL single-dose vial (NDC# 0009-3475-01), b) 25-count box (NDC 0009-3475-03), Rx only, MFG: Pfizer Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-1097-2022 →
  • Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 40 mg/mL, 1 mL single-dose vial, Rx only, MFG: Pfizer, NDC 0009-3073-03 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-1096-2022 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Methylprednisolone in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
5
Strengths
18
Forms in current FDA listings
4 of 5
In current FDA listings No current FDA listing
Ingredient (IN) Methylprednisolone RxCUI 6902
  1. Dose form (SCDF) Injectable Solution RxCUI 376656
    In current FDA listings
    Its strength (SCD)
  2. Dose form (SCDF) Injectable Suspension RxCUI 372866
    In current FDA listings
    Its 3 strengths (SCD)
  3. Dose form (SCDF) Injection RxCUI 1743703
    In current FDA listings
    Its 7 strengths (SCD)
  4. Dose form (SCDF) Oral Tablet RxCUI 372868
    In current FDA listings
    Its 6 strengths (SCD)
    • 2 mg RxCUI 197969
    • 4 mg RxCUI 259966
    • 8 mg RxCUI 197973
    • 16 mg RxCUI 328161
    • 32 mg RxCUI 197971
    • 100 mg RxCUI 199771
  5. Dose form (SCDF) Topical Gel RxCUI 1100386
    No current FDA listing
    Its strength (SCD)
    • 0.01 mg/mg acetate RxCUI 1100387

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Methylprednisolone Supply and Shortage Status

Whether Methylprednisolone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.

Methylprednisolone is currently listed in shortage by the FDA (10 presentations on record).

⚠️Currently in shortage (FDA) — Methylprednisolone

Read the full Methylprednisolone shortage page — affected NDCs, other makers, and what to do →

Current Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Reason: Demand increase for the drug
Current Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Current Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Current Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Reason: Demand increase for the drug
Current Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Reason: Demand increase for the drug
Current Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Reason: Other
Current Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Current Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Reason: Other
Current Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026
Current Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22)
Pfizer Inc. · Since 12/15/2021 · Updated 11/20/2026

Source: openFDA, from the FDA Drug Shortages database.

What Methylprednisolone Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Methylprednisolone: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a form, the generic or the brand, and a strength to see how its price has changed since Nov 2023.

Form
Version
Strength

At this strength, Depo-Medrol costs pharmacies $6.69 per mL.

For the generic 40 mg/mL injection, pharmacies paid an average of $5.57 per mL as of Nov 18, 2026, down 4% from $5.80 a year earlier. At this strength, Depo-Medrol costs pharmacies $6.69 per mL.

What pharmacies pay now
$5.57
per mL, as of Nov 18, 2026
Last 4 weeks
No change
from $5.57 on Oct 21, 2026
Last 12 months
Down 4%
from $5.80 on Nov 19, 2025
Lowest and highest since Apr 2024
$5.31 to $6.51
per mL

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 40 mg/mL injection: the average pharmacy price per mL, the last survey of each month
MonthPharmacy price
Nov 2026$5.57
Oct 2026$5.57
Sep 2026$5.81
Aug 2026$5.81
Jul 2026$5.81
Jun 2026$5.81
May 2026$5.81
Apr 2026$5.81
Mar 2026$5.87
Feb 2026$5.90
Jan 2026$5.94
Dec 2025$5.88
Nov 2025$5.80
Oct 2025$5.73
Sep 2025$5.71
Aug 2025$6.51
Jul 2025$6.51
Jun 2025$6.51
May 2025$6.51
Apr 2025$6.51
Mar 2025$6.51
Feb 2025$6.38
Jan 2025$6.25
Dec 2024$6.07
Nov 2024$5.97
Oct 2024$5.97
Sep 2024$5.70
Aug 2024$5.68
Jul 2024$5.32
Jun 2024$5.31
May 2024$5.33
Apr 2024$5.66
See all 14 prices in a table
FormStrengthVersion What pharmacies pay
Injection · Intra-articular, Intralesional, Intramuscular, Intrasynovial, Soft Tissue 40 mg/mL Generic $5.57–$7.49 per mL NDC details & price history
Injection · Intra-articular, Intralesional, Intramuscular, Soft Tissue 40 mg/mL Depo-Medrol (brand) $6.69 per mL NDC details & price history
Injection · Intramuscular, Intravenous 40 mg/mL Solu-medrol (brand) $6.28 each NDC details & price history
Injection · Intra-articular, Intralesional, Intramuscular, Soft Tissue 80 mg/mL Generic $11.92 per mL NDC details & price history
Injection · Intralesional, Intramuscular, Intrasynovial, Soft Tissue 80 mg/mL Depo-Medrol (brand) $11.93 per mL NDC details & price history
Injection · Intramuscular, Intravenous 125 mg Generic $3.27 each NDC details & price history
Injection · Intramuscular, Intravenous 125 mg/2 mL Generic $3.27 each NDC details & price history
Injection · Intramuscular, Intravenous 125 mg/2 mL Solu-medrol (brand) $10.04 each NDC details & price history
Tablet · Oral 2 mg Medrol (brand) $1.57 per tablet NDC details & price history
Tablet · Oral 4 mg Generic $0.113 per tablet NDC details & price history
Tablet · Oral 4 mg Medrol (brand) $0.245–$0.292 per tablet NDC details & price history
Tablet · Oral 8 mg Generic $0.918 per tablet NDC details & price history
Tablet · Oral 16 mg Generic $1.55 per tablet NDC details & price history
Tablet · Oral 32 mg Generic $2.43 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Methylprednisolone Brand Names

Methylprednisolone has 4 brand names on record: Medrol, HybriSil, Solu-medrol and Depo-Medrol. Medrol, Solu-medrol and Depo-Medrol are in the FDA’s product directory today; HybriSil is not. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Medrol the first brand, 1957 HybriSil not listed today Solu-medrol before 1982 Depo-Medrol before 1982

Who Makes Methylprednisolone: Manufacturers and Labelers

41 companies list Methylprednisolone products with the FDA. By number of product records, the largest are Pharmacia & Upjohn Company LLC, A-S Medication Solutions, Amneal Pharmaceuticals LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Pharmacia & Upjohn Company LLC 16 A-S Medication Solutions 9 Amneal Pharmaceuticals LLC 7 Eugia US LLC 6 Remedyrepack Inc. 6 Asclemed USA, Inc. 5 Chartwell RX, LLC 5 Hikma Pharmaceuticals USA Inc. 5 Sportpharm LLC 5 Tianjin Kingyork Pharmaceuticals Co., Ltd 5 Cardinal Health 107, LLC 4 Dr. Reddy's Laboratories Inc 4 Mylan Pharmaceuticals Inc. 4 Zydus Lifesciences Limited 4 Zydus Pharmaceuticals USA Inc. 4 Advanced Rx Pharmacy of Tennessee, LLC 3 Bryant Ranch Prepack 3 Fresenius Kabi USA, LLC 3 Medical Purchasing Solutions, LLC 3 Proficient Rx LP 3 Amneal Pharmaceuticals NY LLC 2 Caplin Steriles Limited 2 Civica, Inc. 2 HF Acquisition Co LLC, DBA HealthFirst 2

…and 17 more on the FDA NDC directory.

Sources for This Methylprednisolone Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jun 25, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Methylprednisolone.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 55 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
55
Finished products in the current FDA directory
133
Companies listing them (makers, repackagers, distributors)
41
FDA labeler codes behind them ⓘ
44
Linked representative label ⓘ
Pharmacia & Upjohn Company LLC
Linked label effective
Jun 25, 2026
Composite sections available
16
Linked SPL Set ID
7271310c-7764-4812-aa30-a5e90987c7a9
Linked SPL Document ID
9fdbd924-74fd-4b07-882c-d7e11b1a4642
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Pharmacia & Upjohn Company LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →